Business Description
Bio View Ltd
ISIN : IL0010960495
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.88 | |||||
Equity-to-Asset | 0.65 | |||||
Debt-to-Equity | 0.13 | |||||
Debt-to-EBITDA | 1.26 | |||||
Interest Coverage | 8.81 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 1.83 | |||||
Beneish M-Score | -0.15 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 10.6 | |||||
3-Year EBITDA Growth Rate | 7.3 | |||||
3-Year EPS without NRI Growth Rate | -20.6 | |||||
3-Year Book Growth Rate | 4.3 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 47.19 | |||||
9-Day RSI | 49.83 | |||||
14-Day RSI | 50.51 | |||||
6-1 Month Momentum % | -12.12 | |||||
12-1 Month Momentum % | -16.64 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.68 | |||||
Quick Ratio | 2.15 | |||||
Cash Ratio | 1.44 | |||||
Days Inventory | 293.42 | |||||
Days Sales Outstanding | 142.76 | |||||
Days Payable | 99.22 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 1.3 | |||||
Shareholder Yield % | 1.42 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 58 | |||||
Operating Margin % | 6.82 | |||||
Net Margin % | 3.89 | |||||
FCF Margin % | 5.14 | |||||
ROE % | 2.3 | |||||
ROA % | 1.54 | |||||
ROIC % | 3.57 | |||||
ROC (Joel Greenblatt) % | 26.59 | |||||
ROCE % | 6.81 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 58.2 | |||||
PE Ratio without NRI | 58.2 | |||||
Shiller PE Ratio | 22.78 | |||||
PS Ratio | 2.39 | |||||
PB Ratio | 1.43 | |||||
Price-to-Tangible-Book | 1.46 | |||||
Price-to-Free-Cash-Flow | 41.57 | |||||
Price-to-Operating-Cash-Flow | 36.38 | |||||
EV-to-EBIT | 11.46 | |||||
EV-to-EBITDA | 8.81 | |||||
EV-to-Revenue | 1.48 | |||||
EV-to-FCF | 28.74 | |||||
Price-to-Projected-FCF | 1.32 | |||||
Price-to-Graham-Number | 1.94 | |||||
Price-to-Net-Current-Asset-Value | 2.24 | |||||
Price-to-Net-Cash | 14.55 | |||||
Earnings Yield (Greenblatt) % | 8.73 | |||||
FCF Yield % | 2.24 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Bio View Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₪) | 16.65 | ||
EPS (TTM) (₪) | 0.005 | ||
Beta | 0 | ||
Volatility % | 12.62 | ||
14-Day RSI | 50.51 | ||
14-Day ATR (₪) | 0.01648 | ||
20-Day SMA (₪) | 0.28745 | ||
12-1 Month Momentum % | -16.64 | ||
52-Week Range (₪) | 0.271 - 0.373 | ||
Shares Outstanding (Mil) | 133.97 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Bio View Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Bio View Ltd Stock Events
Event | Date | Price(₪) | ||
---|---|---|---|---|
No Event Data |
Bio View Ltd Frequently Asked Questions
What is Bio View Ltd(XTAE:BIOV)'s stock price today?
When is next earnings date of Bio View Ltd(XTAE:BIOV)?
Does Bio View Ltd(XTAE:BIOV) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |